Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Amedeo Minichino

MD DPhil

Wellcome Trust Early Career Fellow

I am a clinical academic psychiatrist with a specific interest in early detection and preventive interventions. 

I am the clinical lead for OPEN - the Oxford Preventive and Early interventioN service, which seek to help young people 'at risk' of developing severe mental illness, such as psychosis, depression, and bipolar disorder. 

My research focuses on clarifying the role of the gut microbiome in the pathophysiology of mental illness and in modulating the efficacy and tolerability of psychotropic medications. I use an inter-disciplinary approach combining clinical, in vitro, and animal models. This is possible thanks to an extended network of collaborators within and beyond the Department of Psychiatry and the University of Oxford.   

My overall aim is to develop methods that will support a more personalised approach to
treatment, with the selection of medications informed by each individual’s microbiome
profile, such that they receive the treatment that is most likely to be effective and least likely to cause
side effects.